Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Code:
NCT05309785
Conditions
ESRD
CKD Stage 4
CKD Stage 5
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Invokana 300 mg and 100 mg tablet
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2025-01-08.